No Detail Found!

Influence of Obesity on Gleason Score Inconsistencies Between Biopsy and Radical Prostatectomy Specimens.

Author(s)
Aytac Sahin Department of Urology, University of Health Science, Fatih Sultan Mehmet Research and Training Hospital, Istanbul, Turkey
Ahmet Urkmez Department of Urology, University of Health Science, Haydarpasa Numune Research and Training Hospital, Istanbul, Turkey
Ozgur Haki Yuksel Department of Urology, University of Health Science, Fatih Sultan Mehmet Research and Training Hospital, Istanbul, Turkey
Ayhan Verit Department of Urology, University of Health Science, Fatih Sultan Mehmet Research and Training Hospital, Istanbul, Turkey
Abstract
Objective: To evaluate the association of obesity with Gleason scores determined in biopsy and radical prostatectomy specimens. Study Design: Cohort study. Place and Duration of Study: Urology Department, Fatih Sultan Mehmet Research Hospital, Istanbul, Turkey from 2007 to 2015. Methodology: A total of 111 patients, younger than 65 years who underwent radical prostatectomy (RP) with the diagnosis of prostate cancer, were included in the study. Histopathology reports of the surgical, and TRUS-guided prostate biopsy specimens were analysed. Body mass index (BMI) and prostate specific antigen (PSA) levels were also evaluated. Results: Mean age of the patients was 59.06 ±4.10 (range = 47-64 years) years. Mean BMI of the patients was 25.59 ±3.24 kg/m2 (range = 19-35 kg/m2). In patients whose BMI measurements were equal or above 25 kg/m2; a significant difference was found between Gleason scores of the needle biopsy and RP specimens (p=0.001). Conclusion: BMI and PSA, which are known to be the most important parameters effecting Gleason score, were evaluated in combination. Regarding non-concordance with Gleason scores, it has been observed that as a predisposing factor, obesity can explain these incompatibilities similarly to PSA.
Publication Details
Page(s) 541-545
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 7, Year: 2018

Request the full text from PASTIC

References
PinthusJH,WitkosM,FleshnerNE,SweetJ,EvansA,JewettMA, 2006.Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome,J Urol 176 979 -84
ArslanE,OzcelikF,DemirbasS., 2013.Cancer types related to obesity,Anatol J Clin Investig 7 176 -84
WilsonKM,GiovannucciEL,MucciLA, 2012.Lifestyle and dietary factors in the prevention of lethal prostate cancer,Asian J Androl 14 365 -74
CalleEE,Kaaks R, 2004.Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms,Nat Rev Cancer 4 579 -91
RobertsDL,DiveC,RenehanAG, 2010.Biological mechanisms linking obesity and cancer risk: new perspectives,Annu Rev Med 61 301 -16
KhandekarMJ,CohenP,SpiegelmanBM, 2011.Molecular mechanisms of cancer development in obesity,Nat Rev Cancer 11 886 -95
BaillargeonJ,PlatzEA,RoseDP,PollockBH,AnkerstDP,HaffnerS, 2006.Obesity, adipokines, and prostate cancer in a prospective population-based study,Cancer Epidemiol Biomarkers Prev 15 1331 -5
EngelandA,TretliS,BjørgeT, 2003.body mass index, and prostate cancer: a follow-up of 950000 Norwegian men,Br J Cancer 89 1237 -42
AnderssonSO,WolkA,BergstromR,AdamiHO,EngholmG,EnglundA, 1997.Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers,J Natl Cancer Inst 89 385 -9
WrightME,ChangSC,SchatzkinA,AlbanesD,KipnisV,MouwT, 2007.Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality,Cancer 109 675 -84
RodriguezC,FreedlandSJ,DekaA,JacobsEJ,McCulloughML,PatelAV, 2007.Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort,Cancer Epidemiol Biomarkers Prev 16 63 -9
MajorJM,Klonoff-CohenHS,PierceJP,SlymenDJ,SaltzsteinSL,MaceraCA, 2011.Prostate cancer postoperative nomogram scores and obesity,PLoS One 6 e17382 -
ZhangX,ZhouG,SunB,ZhaoG,LiuD,SunJ, 2015.Impact of obesity upon prostate cancer-associated mortality: A metaanalysis of 17 cohort studies,Oncol Lett 9 1307 -12
MaJ,LiH,GiovannucciE,MucciL,QiuW,NguyenPL, 2008.Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis,Lancet Oncology 9 1039 -47
VidalAC,HowardLE,MoreiraDM,Castro-SantamariaR,AndrioleGL, 2014.Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study,Cancer Epidemiol Biomarkers Prev 23 2936 -42
DiscacciatiA,OrsiniN,WolkA, 2012.Body mass index and incidence of localized and advanced prostate cancer - a doseresponse meta-analysis of prospective studies,Ann Oncol 23 1665 -71
FreedlandSJ,IsaacsWB,MangoldLA,YiuSK,GrubbKA,PartinAW, 2005.Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years,Clin Cancer Res 11 2883 -8
KaneCJ,BassettWW,SadetskyN,SilvaS,WallaceK,PastaDJ, 2005.Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE,J Urol 173 732 -6
IremashviliV,SolowayMS,RosenbergDL,ManoharanM., 2012.Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance,J Urol 187 1594 -9
BanezLL,HamiltonRJ,PartinAW,VollmerRT,SunL,RodriguezC, 2007.Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer,J Am Med Assoc 298 2275 -80
EfstathiouJA,ChenMH,RenshawAA,LoffredoMJ,D, 2007.Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer,Cancer 109 1493 -8
de CobelliO,TerraccianoD,TagliabueE,RaimondiS,GalassoG,CioffiA, 2015.Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance,Urol Oncol 33 201 -8
TruongM,SlezakJA,LinCP,IremashviliV,SadoM,RazmariaAA, 2013.Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer,Cancer 119 3992 -4002
HeB,ChenR,GaoX,RenS,YangB,HouJ, 2016.Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation,Oncotarget 7 17275 -85
PloussardG,de la TailleA,BayoudY,DurandX,TerryS,XylinasE, 2012.The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillance,Eur Urol 61 356 -62
0

Citations

0

Downloads

79

Views